KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,110
-110 (-0.77%)
Last updated: May 12, 2025

KOREA PHARMA Revenue

In the year 2024, KOREA PHARMA had annual revenue of 81.28B KRW, down -2.36%. KOREA PHARMA had revenue of 21.94B in the quarter ending December 31, 2024, with 7.22% growth.

Revenue
81.28B
Revenue Growth
-2.36%
P/S Ratio
1.92
Revenue / Employee
606.55M
Employees
134
Market Cap
155.97B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202481.28B-1.96B-2.36%
Dec 31, 202383.24B2.21B2.73%
Dec 31, 202281.03B1.45B1.83%
Dec 31, 202179.58B8.07B11.28%
Dec 31, 202071.51B5.37B8.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.07T
SK hynix 71.40T
LG Energy Solution 25.76T
Samsung Biologics 4,547.32B
Hyundai Motor Company 178.98T
Hanwha Aerospace 11.24T
HD Hyundai Heavy Industries 14.49T
Kia Corporation 107.45T
Revenue Rankings